The company also reported GAAP net income of $8.5 million for the second quarter of 2012, compared to GAAP net income of $0.7 million for the second quarter of 2011. However, the company’s United States spine business reported a 4 percent decrease over the same period last year, reaching only $45.7 million in the second quarter.
In the United States, the orthopedics business grew 22 percent to $80.7 million but dropped 2 percent internationally. The company’s U.S. neurosurgery market grew only 2 percent while the international market saw a 5 percent decrease. Worldwide, the neurosurgery market decreased by 1 percent to $67.7 million.
“We had a good quarter across all our businesses and are making solid progress against our priorities,” said Peter Arduini, Integra LifeSciences president and CEO. “Revenues, gross margin and earnings per share all increased both year-over-year and sequentially.”
More Articles on Orthopedic Devices:
Minimally Invasive Surgery Market to Reach $35.5B by 2016
MiMedx Revenues Reach $4.9M in 2Q, 153% Increase
China Device Market Expected Grew at 20.5% CAGR From 2006-2011
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.